共 128 条
[1]
Singer M(2016)The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA 315 801-377
[2]
Deutschman CS(2017)Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 Intensive Care Med 43 304-637
[3]
Seymour CW(2007)Catecholamine treatment for shock—equally good or bad? Lancet 370 636-2168
[4]
Shankar-Hari M(2009)Bench-to-bedside review: β-adrenergic modulation in sepsis Crit Care 13 230-2772
[5]
Annane D(2013)Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial JAMA 310 1683-582
[6]
Bauer M(2013)Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study* Crit Care Med 41 2162-143
[7]
Rhodes A(2012)Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis* Crit Care Med 40 2768-1825
[8]
Evans LE(2017)Outpatient beta-blockers and survival from sepsis: results from a national cohort of Medicare beneficiaries Am J Surg 214 577-1612
[9]
Alhazzani W(2019)Hemodynamic response to β-blockers in severe sepsis and septic shock: a review of current literature J Crit Care 50 138-1558
[10]
Levy MM(2015)Systematic review of use of β-blockers in sepsis J Anaesthesiol Clin Pharmacol 31 460-2622